SRPX2 boosts pancreatic cancer chemoresistance by activating PI3K/AKT axis
This investigation was aimed at disclosing whether SRPX2 affected pancreatic cancer (PC) chemoresistance by regulating PI3K/Akt/mTOR signaling.
Main Authors: | , , , , |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
De Gruyter
2020-10-01
|
Colecção: | Open Medicine |
Assuntos: | |
Acesso em linha: | https://doi.org/10.1515/med-2020-0157 |